Journal of General Virology, Vol 80, 761-765, Copyright © 1999 by Society for General Microbiology

ARTICLES

Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection

JA Karlas, KH Siebelink, MA Peer, W Huisman, AM Cuisinier, GF Rimmelzwaan and AD Osterhaus
Institute of Virology, Erasmus University Rotterdam, The Netherlands.

Cats were vaccinated with fixed autologous feline immunodeficiency virus (FIV)-infected cells in order to present viral proteins to the immune system of individual cats in an MHC-matched fashion. Upon vaccination, a humoral response against Gag was induced. Furthermore, virus-neutralizing antibodies were detected in a Crandell feline kidney cell-based neutralization assay, but not in a neutralization assay based on primary peripheral blood mononuclear cells. Despite the induction of these FIV-specific responses, vaccinated cats were not protected. Instead, accelerated virus replication was found, an observation similar to what previous experiments using other vaccine candidates have shown. Here, the results of the present study are discussed in the light of enhancement of lentivirus infections as a complicating factor in lentivirus vaccine development.

This article has been cited by other articles:

				S. Giannecchini, A. M. D'Ursi, C. Esposito, M. Scrima, E. Zabogli, G. Freer, P. Rovero, and M. Bendinelli Antibodies Generated in Cats by a Lipopeptide Reproducing the Membrane-Proximal External Region of the Feline Immunodeficiency Virus Transmembrane Enhance Virus Infectivity Clin. Vaccine Immunol., August 1, 2007; 14(8): 944 - 951. [Abstract] [Full Text] [PDF]

				T. van Montfort, A. A. Nabatov, T. B. H. Geijtenbeek, G. Pollakis, and W. A. Paxton Efficient Capture of Antibody Neutralized HIV-1 by Cells Expressing DC-SIGN and Transfer to CD4+ T Lymphocytes J. Immunol., March 1, 2007; 178(5): 3177 - 3185. [Abstract] [Full Text] [PDF]

				M. Pistello, F. Bonci, J. N. Flynn, P. Mazzetti, P. Isola, E. Zabogli, V. Camerini, D. Matteucci, G. Freer, P. Pelosi, et al. AIDS Vaccination Studies with an Ex Vivo Feline Immunodeficiency Virus Model: Analysis of the Accessory ORF-A Protein and DNA as Protective Immunogens. J. Virol., September 1, 2006; 80(18): 8856 - 8868. [Abstract] [Full Text] [PDF]

				A. Moris, A. Pajot, F. Blanchet, F. Guivel-Benhassine, M. Salcedo, and O. Schwartz Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer Blood, September 1, 2006; 108(5): 1643 - 1651. [Abstract] [Full Text] [PDF]

				S. Broche-Pierre, J. Richardson, A. Moraillon, and P. Sonigo Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties J. Gen. Virol., September 1, 2005; 86(9): 2495 - 2506. [Abstract] [Full Text] [PDF]

				W. Huisman, E. J. A. Schrauwen, S. D. Pas, J. A. Karlas, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats J. Gen. Virol., July 1, 2004; 85(7): 1833 - 1841. [Abstract] [Full Text] [PDF]

				J. Richardson, S. Broche, S. Baud, T. Leste-Lasserre, F. Femenia, D. Levy, A. Moraillon, G. Pancino, and P. Sonigo Lymphoid activation: a confounding factor in AIDS vaccine development? J. Gen. Virol., October 1, 2002; 83(10): 2515 - 2521. [Abstract] [Full Text] [PDF]

				S. Giannecchini, P. Isola, O. Sichi, D. Matteucci, M. Pistello, L. Zaccaro, D. Del Mauro, and M. Bendinelli AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts J. Virol., June 14, 2002; 76(14): 6882 - 6892. [Abstract] [Full Text] [PDF]